Email updates

Keep up to date with the latest news and content from Epigenetics & Chromatin and BioMed Central.

This article is part of the supplement: Epigenetics and Chromatin: Interactions and processes

Open Access Open Badges Poster presentation

DNA methylation alone does not cause most cell-type selective transcription factor binding

Matthew T Maurano1*, Hao Wang1, Anthony Shafer1, Sam John1 and John A Stamatoyannopoulos12

  • * Corresponding author: Matthew T Maurano

  • † Equal contributors

Author Affiliations

1 Departments of Genome Sciences, Division of Oncology, University of Washington, Seattle, WA, 98195, USA

2 Medicine, Division of Oncology, University of Washington, Seattle, WA, 98195, USA

For all author emails, please log on.

Epigenetics & Chromatin 2013, 6(Suppl 1):P103  doi:10.1186/1756-8935-6-S1-P103

The electronic version of this article is the complete one and can be found online at:

Published:18 March 2013

© 2013 Maurano et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


DNA methylation at vertebrate promoters is associated with the repression of gene expression and is required for mammalian development [1]. The master genome regulator and transcription factor CTCF canonically exhibits methylation-sensitive binding in vitro, and its in vivo occupancy across cell types anticorrelates with methylation at 41 % of sites genome-wide [2]. However, the genome harbors hundreds of thousands of CTCF recognition sequences, the majority of which are unbound in any cell type. Although most unbound recognition sequences harbor methylation in a given cell type, the causal role of DNA methylation in the abrogation of transcription factor binding at these potential binding sites is largely unknown [3,4].

Materials and methods

Here we perform genome-wide occupancy profiling after both stable genetic and transient chemical inhibition of DNA methyltransferases in HCT116 cells lacking functional DNMT1 and DNMT3b and K562 erythroleukemia cells treated with 5-aza-2-deoxycytidine.


We show that the vast majority of susceptible binding sites remain unoccupied upon depletion of DNA methylation. Stable loss of methylation in HCT116 cells does result in a minor increase of several thousand binding sites, largely corresponding to selective reactivation of binding sites from other cell types, especially from other malignant cell lines. Chemical inhibition in K562 cells results in a smaller but reproducible set of several hundred reactivated sites, the majority of which are corroborated by the genetic data. The narrow extent of reactivation implies that the majority of transcription factor recognition sequences are not competent for binding even in the absence of methylation, and that methylation accounts for only a modest fraction of cell-selective binding. These results offer new insight into the establishment of the global regulatory landscape, and offer an important perspective on the interpretation of disease- and trait-associated methylation differences in humans.


This work was supported by the National Institutes of Health under a Ruth L. Kirschstein National Research Service Award from NIMH [1F31MH094073 to M.T.M.]. We thank Bert Vogelstein for graciously sharing DNMT1/3b DKO HCT116 cells.


  1. Jones PA: Functions of DNA methylation: islands, start sites, gene bodies and beyond.

    Nat Rev Genet 2012, 13:484-492. PubMed Abstract | Publisher Full Text OpenURL

  2. Wang H, Maurano MT, Qu H, Varley KE, Gertz J, Pauli F, Lee K, Canfield T, Weaver M, Sandstrom R, Thurman RE, Kaul R, Myers RM, Stamatoyannopoulos JA: Widespread plasticity in CTCF occupancy linked to DNA methylation.

    Genome Res 2012, 22:1680-1688. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  3. Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Schöler A, Wirbelauer C, Oakeley EJ, Gaidatzis D, Tiwari VK, Schübeler D: DNA-binding factors shape the mouse methylome at distal regulatory regions.

    Nature 2011, 480:490-495. PubMed Abstract | Publisher Full Text OpenURL

  4. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson EM, Kutyavin T, Lajoie B, Lee B-K, Lee K, London D, Lotakis D, Neph S, et al.: The accessible chromatin landscape of the human genome.

    Nature 2012, 489:75-82. PubMed Abstract | Publisher Full Text OpenURL